We investigated nasopharyngeal microbial community structure in COVID-19-positive and -negative patients. High-throughput 16S ribosomal RNA gene amplicon sequencing revealed significant microbial community structure differences between COVID-19-positive and -negative patients. This proof-of-concept study demonstrates that: (1) nasopharyngeal microbiome communities can be assessed using collection samples already collected for SARS-CoV-2 testing (viral transport media) and (2) SARS-CoV-2 infection is associated with altered dysbiotic microbial profiles which could be a biomarker for disease progression and prognosis in SARS-CoV-2.
CITATION STYLE
Engen, P. A., Naqib, A., Jennings, C., Green, S. J., Landay, A., Keshavarzian, A., & Voigt, R. M. (2021). Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients. Biological Procedures Online, 23(1). https://doi.org/10.1186/s12575-021-00148-6
Mendeley helps you to discover research relevant for your work.